nitrites has been researched along with raloxifene hydrochloride in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 5 (83.33) | 29.6817 |
2010's | 1 (16.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bayraktar, F; Oge, A; Ozgönül, M; Sezer, ED; Sözmen, EY | 1 |
Cerquetani, E; Fini, M; Mercuro, G; Rosano, GM; Vitale, C; Zoncu, S | 1 |
Baetta, R; Bolego, C; Cignarella, A; Corsini, A; Gaion, RM; Pelosi, V; Pinna, C; Sanvito, P | 1 |
Kim, BC; Lee, SA; Park, SH | 1 |
Armagan, G; Kanit, L; Sozmen, EY; Terek, CM; Yalcin, A | 1 |
Abreu, GR; Bissoli, NS; Gonçalves, WL; Gouvêa, SA; Moraes, AN; Moyses, MR; Pires, JG; Romero, WG | 1 |
1 trial(s) available for nitrites and raloxifene hydrochloride
Article | Year |
---|---|
Comparative vascular effects of hormone replacement therapy and raloxifene in women at increased cardiovascular risk.
Topics: Aged; Brachial Artery; Cardiovascular Diseases; Cross-Over Studies; Double-Blind Method; Endothelin-1; Endothelium, Vascular; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Nitrates; Nitrites; Postmenopause; Pulsatile Flow; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Treatment Outcome; Vasodilation | 2004 |
5 other study(ies) available for nitrites and raloxifene hydrochloride
Article | Year |
---|---|
The effects of estrogen and raloxifene treatment on the antioxidant enzymes and nitrite-nitrate levels in brain cortex of ovariectomized rats.
Topics: Animals; Catalase; Cerebral Cortex; Ethinyl Estradiol; Female; Nitrates; Nitric Oxide; Nitrites; Ovariectomy; Raloxifene Hydrochloride; Rats; Rats, Sprague-Dawley; Selective Estrogen Receptor Modulators; Superoxide Dismutase | 2003 |
Raloxifene elicits combined rapid vasorelaxation and long-term anti-inflammatory actions in rat aorta.
Topics: Animals; Anti-Inflammatory Agents; Aorta, Thoracic; Blotting, Western; Cell Survival; Estradiol; Estrogen Receptor alpha; Estrogen Receptor beta; Female; Fulvestrant; In Vitro Techniques; Isometric Contraction; Kinetics; Lipopolysaccharides; Muscle Relaxation; Muscle, Smooth, Vascular; Nitrites; Ovariectomy; Raloxifene Hydrochloride; Rats; Selective Estrogen Receptor Modulators | 2006 |
Raloxifene, a selective estrogen receptor modulator, inhibits lipopolysaccharide-induced nitric oxide production by inhibiting the phosphatidylinositol 3-kinase/Akt/nuclear factor-kappa B pathway in RAW264.7 macrophage cells.
Topics: Animals; Cells, Cultured; Down-Regulation; Electrophoretic Mobility Shift Assay; Fluorescent Antibody Technique, Indirect; Immunoblotting; Lipopolysaccharides; Luciferases; Macrophages; MAP Kinase Kinase 4; Mice; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; NF-kappa B; Nitric Oxide; Nitric Oxide Synthase Type II; Nitrites; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators | 2008 |
The levels of glutathione and nitrite-nitrate and the expression of Bcl-2 mRNA in ovariectomized rats treated by raloxifene against kainic acid.
Topics: Animals; Apoptosis; Disease Models, Animal; Female; Glutathione; Kainic Acid; Nerve Degeneration; Neuroprotective Agents; Nitrates; Nitric Oxide; Nitrites; Ovariectomy; Oxidative Stress; Proto-Oncogene Proteins c-bcl-2; Raloxifene Hydrochloride; Rats; Rats, Sprague-Dawley; Receptors, Estrogen; RNA, Messenger; Selective Estrogen Receptor Modulators; Treatment Outcome; Up-Regulation | 2009 |
Raloxifene reduces blood pressure in hypertensive animals after ovarian hormone deprivation.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Diuresis; Drug Evaluation, Preclinical; Female; Hypertension; Nitrates; Nitrites; Ovariectomy; Raloxifene Hydrochloride; Rats; Rats, Wistar; Sodium | 2011 |